Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: andy71 who wrote (11507)	12/19/2018 11:18:50 PM
From: HardToFind	Respond to of 12873

So you concede it works htf.... First, I believe it works. I don't know it works, but it's not among my first round of worries. Will I feel relieved when human data comes out positive. You concede they can make enough.... Yes, given enough money...they can eventually make enough. And you concede there is no toxicity.... I believe toxicity is low. The issue is much more complex than your question seems to imply. I don't think this is a given for every drug candidate, but it seems pretty doable for a given indication. And you concede if it works for one it works for all... Absolutely not. It is a virus-by-virus challenge (or maybe virus-family-by-virus-family challenge). Ebola hasn't been made to work at all yet.